Search

Search Constraints

You searched for: Author/Creator van der Meer, Renske

Search Results

2. Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial. Issue 10212 (23rd November 2019)

3. Forskolin-induced organoid swelling is associated with long-term cystic fibrosis disease progression. Issue 2 (18th August 2022)

4. Long-term safety and efficacy of tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR (EXTEND): an open-label extension study. Issue 7 (July 2021)